Brand Name : Infovir
Generic Name : Acyclovir Intravenous Infusion IP
Pack Size : Vial + WFI
Dosage Form : Intravenous Infusion
Strength : 250 mg & 500 mg
Therapeutic indications : Acyclovir. is indicated for the treatment of Herpes simplex infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised.
Acyclovir. is indicated for the prophylaxis of Herpes simplex infections in immunocompromised patients.
Acyclovir. is indicated for the treatment of Varicella zoster infections.
Acyclovir. is indicated for the treatment of herpes encephalitis.
Acyclovir. is indicated for the treatment of Herpes simplex infections in the neonate and infant up to 3 months of age.
Pharmacotherapeutic group : Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors
ATC code : J05AB01
Pharmacodynamic properties : Acyclovir is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against human herpes viruses, including Herpes simplex virus types 1 and 2 and Varicella zoster virus (VZV), Epstein Barr virus (EBV) and Cytomegalovirus (CMV). In cell culture Acyclovir has the greatest antiviral activity against HSV-1, followed (in decreasing order of potency) by HSV-2, VZV, EBV and CMV.
February 18, 2022